Wall Street’s Key Stock Analysts Research Report, All Buys

Wall Street’s Key Stock Analysts Research Report, All Buys

$CRL, $HLF, $IPHI, $PODD, $MSI, $SPTN

These are all Buys if you can manage the risk.

Daily HeffX-LTN reviews dozens of Wall Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.

Below is our list for Monday, 11 May, as follows:

Charles River Laboratories International Inc. (NYSE:CRL) was reiterated as Buy and its price target was raised to 190 from 165 at Citigroup.

Herbalife Nutrition Ltd. (NYSE:HLF) was reiterated as Buy and its price target was raised to 56 from 49 at Citigroup. Shares closed 41.23 Friday after earnings. Shares have a 48.00 consensus price target.

Inphi Corp. (NASDAQ:IPHI) Needham reiterated its Buy rating and raised its price target to 122 from 100.

Insulet Corp. (NASDAQ:PODD) was reiterated as Buy and its target was raised to 250 from 205 at Citigroup. The stock closed up 217.63 + 1.15% and previously had a 190.06 consensus analyst target.

Motorola Solutions Inc. (NYSE:MSI) was maintained with a Buy rating but its price target was cut to 160 from 175 at Citigroup.

SpartanNash Co. (NASDAQ:SPTN) as local grocery stores offer strong earnings in this C-19 coronavirus chaos. Shares closed Friday at 17.92, +10.96%, with a consensus price target of 17.33.

Have a healthy week, Keep the Faith!

The following two tabs change content below.

Paul Ebeling

Paul A. Ebeling, a polymath, excels, in diverse fields of knowledge Including Pattern Recognition Analysis in Equities, Commodities and Foreign Exchange, and he it the author of "The Red Roadmaster's Technical Report on the US Major Market Indices, a highly regarded, weekly financial market commentary. He is a philosopher, issuing insights on a wide range of subjects to over a million cohorts. An international audience of opinion makers, business leaders, and global organizations recognize Ebeling as an expert.